Literature DB >> 4699105

Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.

E L Denijs, J L Vereecken.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4699105

Source DB:  PubMed          Journal:  Psychiatr Neurol Neurochir        ISSN： 0033-2666


× No keyword cloud information.
  4 in total

Review 1.  Antipsychotic medication for elderly people with schizophrenia.

Authors:  R G Marriott; W Neil; S Waddingham
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

Review 2.  The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.

Authors:  Marc De Hert; Jan Sermon; Paul Geerts; Kristof Vansteelandt; Joseph Peuskens; Johan Detraux
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 3.  Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry.

Authors:  R M Pinder; R N Brogden; R Swayer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

4.  Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide.

Authors:  R M Post; D C Jimerson; W E Bunney; F K Goodwin
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.